| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |